Through rank correlation analysis, Study has found a negative correlation between BCL-2 expression and chemotherapy sensitivity of breast cancer, suggesting that BCL-2 may make breast cancer cells resistant to chemotherapy drugs through its anti-apoptotic function (7). This evidence concerns the gene BCL2 and breast carcinoma.